Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.31% |
| Dec 31, 2025 | 34.52% |
| Sep 30, 2025 | 32.72% |
| Jun 30, 2025 | 31.58% |
| Mar 31, 2025 | 31.00% |
| Dec 31, 2024 | 29.13% |
| Sep 30, 2024 | 24.50% |
| Jun 30, 2024 | 17.11% |
| Mar 31, 2024 | 6.17% |
| Dec 31, 2023 | 5.01% |
| Sep 30, 2023 | 7.32% |
| Jun 30, 2023 | 7.46% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | 1.98% |
| Sep 30, 2022 | -5.17% |
| Jun 30, 2022 | -10.68% |
| Mar 31, 2022 | -10.80% |
| Dec 31, 2021 | -8.13% |
| Sep 30, 2021 | -5.78% |
| Jun 30, 2021 | -2.48% |
| Mar 31, 2021 | -1.76% |
| Dec 31, 2020 | -0.21% |
| Sep 30, 2020 | 7.87% |
| Jun 30, 2020 | 29.17% |
| Mar 31, 2020 | 33.52% |
| Dec 31, 2019 | 40.19% |
| Sep 30, 2019 | 43.38% |
| Jun 30, 2019 | 48.95% |
| Mar 31, 2019 | 52.82% |
| Dec 31, 2018 | 54.54% |
| Sep 30, 2018 | 49.51% |
| Jun 30, 2018 | 48.73% |
| Mar 31, 2018 | 57.96% |
| Sep 30, 2017 | 67.47% |